Analysis of Mice Skin Distribution Using MALDI-MSI After Subcutaneous Injections of a Potent Novel Peptide Hair Growth Promoter, FOL-005

    April 2018 in “ Journal of Investigative Dermatology ”
    D. Bonnel, Raphael Legouffe, Margareta Ekblad, F. Farcette, Jonathan Stauber, Jan Alenfall
    Image of study
    TLDR FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.
    The document presents a study on the distribution of a novel peptide, FOL-005, which promotes hair growth, in mouse skin following subcutaneous injections. The study aimed to support the clinical development of FOL-005 as a treatment for alopecia. Using MALDI-MSI technology, which combines mass spectrometry imaging with histology, researchers found that FOL-005 was exclusively distributed in the treated skin area and its concentration decreased over time. No distribution of the peptide was detected outside the skin, indicating local degradation. These findings suggest that FOL-005 acts locally and could be a promising new treatment for hair loss conditions. The study was part of a preclinical program following a clinical phase I/IIa study where FOL-005 was shown to be safe and resulted in an 8% increase in hair growth at one of the doses tested.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 11 results

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  120 upvotes 7 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community FOL005 claims it's better than Finasteride and Minoxidil.

      in Technology  183 upvotes 9 months ago
      FOL-005 claims to be more effective than Minoxidil and Finasteride but lacks anti-DHT properties, leading to potential reduced efficacy over time. Concerns are raised about misleading marketing and the safety of alternative treatments like Pyrilutamide and Clascoterone.

      community Follicum releases some data from previous phase 2a trial

      in Research/Science  13 upvotes 1 year ago
      Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.

      community Status update on upcoming treatments

      in Treatment  43 upvotes 4 weeks ago
      Current treatments like finasteride, minoxidil, and derma rolling are considered the best for hair loss, while new treatments such as GT20029, PP405, and others are in various trial phases with results expected in the coming years. There is cautious optimism about the affordability and effectiveness of these upcoming treatments.

    Similar Research

    5 / 1000+ results